Vol 10, Supp. B (2019)
Case report
Published online: 2019-10-02

open access

Page views 644
Article views/downloads 441
Get Citation

Connect on Social Media

Connect on Social Media

Azacitidine treatment of patient with acute myeloid leukemia secondary to myelofibrosis

Agnieszka Pluta1, Dorota Jesionek-Kupnicka2, Ewa Wawrzyniak1, Agnieszka Wierzbowska1


The treatment of acute myeloid leukemia (AML) is still a medical dilemma, especially in patients with high comorbidities score. Demethylating agents may be the therapeutic option in AML patients under 60-years-old with non-proliferating diseases and high comorbidity index. In this article we presented the case of 57-years-old patient with high-risk secondary to myelofibrosis AML and high comorbidity index, who was treated with azacitidine.

Article available in PDF format

View PDF (Polish) Download PDF file

Hematology in Clinical Practice